UC
UCB S.A.
UCBJF · OTC
$235.10 -5.35% (-$13.30)
1M -4.93%
Market Cap 41.1B €
P/E Ratio 26.40x
Div. Yield 0.68%
ROE 14.76%
Bulios Fair Price
$297.32
26.5% upside
Current Price
$235.1
Undervalued Fair Value Overvalued
According to Bulios Fair Price, UCBJF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
48 /100
Fair EV/EBITDA 20.47x
P/S 5.31x
P/B 3.78x
Growth
87 /100
Growing Rev. growth 11.94%
FCF growth 35.99%
Book val. growth 6.22%
Profitability
100 /100
Strong Net margin 20.13%
Op. margin 25.95%
FCF margin 24.31%
Quality
65 /100
Average ROE 14.76%
ROA 8.58%
Asset turnover 0.43x
Debt
95 /100
Low Current ratio 1.38x
Int. coverage 15.94x
Net debt/EBITDA -0.00x
Stability
36 /100
Moderate Rev. volatility 15.77%
EPS volatility 117.91%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about UCBJF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jean-Christophe Tellier
Employees
10,117
Headquarters
Brussels
Upcoming events
25 FEB
Earnings
Upcoming earnings report